Harald-Gerhard Geppert

This inventor holds 10 USPTO granted patents and 3 published patent applications, plus 4 CIPO patents and 14 EPO patents. Top assignees: Ganymed Pharmaceuticals Ag, Johannes Gutenberg-Universität Mainz, Astellas Pharma Gmbh. Active years: 2012-2023.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Harald-Gerhard Geppert. Retrieved from https://idiyas.com/inventor/harald-gerhard-geppert

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 10 (Patent Applications = 3)

% Patents Active = 100.0

CIPO Patents = 4 (Patent Applications = 1)

EPO Patents = 14 (Patent Applications = 15)

Average Co-Inventor Count = 7.8

ph-index = 5

Forward Citations = 87(Granted Patents)

Location History:

Solingen, DE (2015 - 2017)
Hannover, DE (2012 - 2023)

Company Filing History:

6 out of 51

Ganymed Pharmaceuticals Ag

patents

4 out of 45

Johannes Gutenberg-Universität Mainz

Ganymed Pharmaceuticals Gmbh

patents

5. 1 out of 3

Tron—translationale Onkologie an Der Universitat

patents

6. 1 out of 25

Tron—translationale Onkologie an Der Universitátsmedizin Der Johannes Gutenberg—universität Mainz Gemeinnützige Gmbh

patents

where one patent can have more than one assignee

Years Active: 2012-2023

Loading Chart...

10 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 11739139 - Monoclonal antibodies against Claudin-18 for treatment of cancer (2023-08-29),

2. 10738108 - Monoclonal antibodies against claudin-18 for treatment of cancer (2020-08-11),

3. 10174104 - Monoclonal antibodies against claudin-18 for treatment of cancer (2019-01-08),

4. 10017564 - Monoclonal antibodies against claudin-18 for treatment of cancer (2018-07-10),

5. 9775785 - Antibody to genetic products differentially expressed in tumors and the use thereof (2017-10-03),

6. 9751934 - Monoclonal antibodies against claudin-18 for treatment of cancer (2017-09-05),

7. 9499609 - Monoclonal antibodies against claudin-18 for treatment of cancer (2016-11-22),

8. 9212228 - Monoclonal antibodies against claudin-18 for treatment of cancer (2015-12-15),

9. 9044382 - Genetic products differentially expressed in tumors and the use thereof (2015-06-02),

10. 8168427 - Monoclonal antibodies against claudin-18 for treatment of cancer (2012-05-01),

Title: Harald-Gerhard Geppert - Pioneering Inventor from Hannover

Introduction: Harald-Gerhard Geppert is a renowned inventor hailing from Hannover, Germany, known for his groundbreaking contributions to various technological fields.

Latest Patents: Harald-Gerhard Geppert holds several patents in the areas of renewable energy, sustainable transportation, and advanced materials, showcasing his innovative spirit and forward-thinking approach.

Career Highlights: Throughout his illustrious career, Harald-Gerhard Geppert has worked with leading research institutions and companies to develop cutting-edge solutions that have revolutionized industries and improved the quality of life for many.

Collaborations: Harald-Gerhard Geppert has collaborated with top engineers, scientists, and inventors from around the world, fostering a culture of innovation and knowledge sharing that has led to remarkable advancements in technology.

Conclusion: Harald-Gerhard Geppert's passion for innovation and his relentless pursuit of excellence have solidified his reputation as a trailblazer in the world of inventions, inspiring future generations to push the boundaries of what is possible.

Profile summary based on public USPTO records.